China Lincomycin HCl CAS: 859-18-7

An antibiotic produced by Streptomyces lincolnensis var. lincolnensis. It has been used in the treatment of staphylococcal, streptococcal, and Bacteroides fragilis infections.
It's a narrow-spectrum antibiotic, similar to erythromycin, has a good effect on Gram-positive cocci, especially for anaerobic bacteria, Staphylococcus aureus and pneumococci. Its mechanism of action is similar to that of erythromycin, and it is a bacteriostatic agent. It mainly inhibits the synthesis of bacterial cell proteins. It is mainly used for various infections caused by sensitive bacteria, such as pneumonia, meningitis, endocarditis, cellulitis, tonsillitis, erysipelas, sputum and urinary tract infections. Because this product can enter the bone tissue and has special affinity with bone, it is especially suitable for infection caused by anaerobic bacteria and Staphylococcus aureus.